21st Century Scientific Inc
Letter data
- Company
- 21st Century Scientific Inc
- Recipient
- Ronald D. Davidson | Chief Operating Officer | 21st Century Scientific Inc | 4931 N. Manufacturing Way | Coeur d Alene | , | ID | 83815 | United States | rdd@wheelchairs.com
- Issue date
- 2021-11-04
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 566834
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
21st Century Scientific Inc
MARCS-CMS 566834 —
November 04, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Medical Devices
Recipient:
Recipient Name
Ronald D. Davidson
Recipient Title
Chief Operating Officer
21st Century Scientific Inc
4931 N. Manufacturing Way
Coeur d Alene
,
ID
83815
United States
rdd@wheelchairs.com
Issuing Office:
Center for Devices and Radiological Health
United States
Dear Mr. Davidson:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated May 13, 2019. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica Mu,
Director, Compliance Branch
Office of Medical Devices and
Radiological Health, Division III
Content current as of:
11/04/2021
Regulated Product(s)
Medical Devices